ACH
Accendra Health, Inc.
Accendra Health (ACH) Q2 2026 earnings
Published Aug 10, 2026
AI summary
- Revenue $613M, down 10% from $682M a year ago.
- Adjusted EPS −$0.19 missed the −$0.09 consensus by $0.10, down from $0.26 a year ago.
- Accendra Health reported second quarter revenue of $613.2 million, down from $681.9 million in the prior year.
- The company recorded a GAAP net loss of $1.16 per share for the second quarter.
- Management reduced total debt by $385 million during the quarter through a balance sheet optimization transaction.
Results vs analyst consensus
Revenue
Reported
$613M
Consensus not captured before release
−10% YoY
Adjusted EPS
Reported · Adjusted EPS
−$0.19
Consensus −$0.09
Missed by $0.10GAAP EPS: −$1.16
Consensus: Yahoo Finance · Q2 2026 · EPS estimate at release
Revenue display rounded; difference uses exact result.
Next quarter outlook
$2.45B–$2.55B
full year 2026 revenue guidance
Next-quarter consensus not captured before release.
What to watch
- The company is navigating a commercial payor exit and associated operating expense rationalization.
- GAAP results are impacted by unpredictable restructuring and acquisition charges.
Read original report
Source: Accendra Health, Inc. press release · SEC Form 8-K exhibit 99.1